Creo Medical Group

Minimally Invasive Interventions Will Capture New Global Markets

AnalystConsensusTarget

Not Invested

Consensus Narrative from 3 Analysts

Published

01 Jun 25

Updated

24 Jul 25

AnalystConsensusTarget's Fair Value

UK£0.71

82.3% undervalued

24 Jul

UK£0.13

-55.8%

-10.7%

Author's Valuation

UK£0.7

82.3% undervalued

AnalystConsensusTarget Fair Value

Narrative

Updates0

AnalystConsensusTarget Fair Value

UK£0.7

82.3% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

38.79%

Medical Equipment revenue growth rate

0.32%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

7.60%

Calculation

UK£2.00m

Earnings '28

243.42x

PE Ratio '28

UK£486.87m

Market Cap '28

UK£486.87m

Market Cap '28

552.88m

No. shares '28

UK£0.88

Share Price '28

UK£0.88 Share Price '28

Discounted to 2025 @ 7.61% p.a.

UK£0.71

Fair Value '25